Consistently, high SHMT2 expression correlates with poor differentiation and increased invasion (Ji et al., 2019), while SHMT2 knockdown significantly inhibits HCC cell metastasis and tumor progression (Woo et al., 2016). Here, SHMT2 is linked to hepatocellular carcinoma.